JPMorgan Chase & Co. Issues Positive Forecast for Bath & Body Works (NYSE:BBWI) Stock Price

Bath & Body Works (NYSE:BBWI) had its price objective increased by equities research analysts at JPMorgan Chase & Co. from $35.00 to $39.00 in a report issued on Tuesday,Benzinga reports. The brokerage presently has a “neutral” rating on the stock. JPMorgan Chase & Co.‘s price target suggests a potential upside of 8.57% from the company’s current price.

BBWI has been the subject of several other reports. Barclays lifted their price target on shares of Bath & Body Works from $28.00 to $34.00 and gave the company an “underweight” rating in a research note on Tuesday. Bank of America dropped their price target on Bath & Body Works from $54.00 to $45.00 and set a “buy” rating on the stock in a research note on Thursday, August 29th. Telsey Advisory Group reissued an “outperform” rating and issued a $42.00 price objective on shares of Bath & Body Works in a research note on Monday. Robert W. Baird lowered their target price on Bath & Body Works from $54.00 to $45.00 and set an “outperform” rating on the stock in a research report on Thursday, August 29th. Finally, Raymond James reduced their price target on shares of Bath & Body Works from $51.00 to $42.00 and set an “outperform” rating for the company in a research report on Thursday, August 29th. One analyst has rated the stock with a sell rating, six have given a hold rating and nine have issued a buy rating to the company’s stock. Based on data from MarketBeat.com, the company has an average rating of “Moderate Buy” and an average target price of $41.88.

Bath & Body Works Price Performance

Shares of Bath & Body Works stock opened at $35.92 on Tuesday. The firm has a market cap of $7.87 billion, a price-to-earnings ratio of 8.83, a PEG ratio of 1.14 and a beta of 1.79. The stock’s 50-day moving average is $30.81 and its 200 day moving average is $35.65. Bath & Body Works has a one year low of $26.20 and a one year high of $52.99.

Bath & Body Works (NYSE:BBWI) last announced its quarterly earnings data on Wednesday, August 28th. The company reported $0.37 EPS for the quarter, topping the consensus estimate of $0.35 by $0.02. Bath & Body Works had a net margin of 12.43% and a negative return on equity of 44.03%. The company had revenue of $1.53 billion during the quarter, compared to the consensus estimate of $1.54 billion. On average, sell-side analysts expect that Bath & Body Works will post 3.18 EPS for the current fiscal year.

Insider Buying and Selling

In other Bath & Body Works news, CEO Gina Boswell purchased 6,000 shares of the company’s stock in a transaction that occurred on Wednesday, October 9th. The shares were acquired at an average cost of $29.64 per share, for a total transaction of $177,840.00. Following the completion of the acquisition, the chief executive officer now owns 242,987 shares of the company’s stock, valued at $7,202,134.68. The trade was a 2.53 % increase in their position. The purchase was disclosed in a legal filing with the Securities & Exchange Commission, which is accessible through this link. 0.27% of the stock is owned by corporate insiders.

Institutional Inflows and Outflows

A number of institutional investors have recently bought and sold shares of BBWI. CWM LLC boosted its holdings in shares of Bath & Body Works by 6.6% in the 2nd quarter. CWM LLC now owns 5,072 shares of the company’s stock worth $198,000 after buying an additional 314 shares during the last quarter. Northwest Bank & Trust Co raised its position in Bath & Body Works by 2.5% in the first quarter. Northwest Bank & Trust Co now owns 13,094 shares of the company’s stock worth $655,000 after acquiring an additional 315 shares during the period. DekaBank Deutsche Girozentrale boosted its stake in Bath & Body Works by 1.0% in the first quarter. DekaBank Deutsche Girozentrale now owns 31,797 shares of the company’s stock valued at $1,560,000 after acquiring an additional 322 shares during the last quarter. TD Private Client Wealth LLC boosted its stake in Bath & Body Works by 24.2% in the third quarter. TD Private Client Wealth LLC now owns 1,697 shares of the company’s stock valued at $54,000 after acquiring an additional 331 shares during the last quarter. Finally, Citizens & Northern Corp grew its position in shares of Bath & Body Works by 1.7% during the 2nd quarter. Citizens & Northern Corp now owns 29,465 shares of the company’s stock valued at $1,151,000 after acquiring an additional 487 shares during the period. Institutional investors own 95.14% of the company’s stock.

Bath & Body Works Company Profile

Bath & Body Works, Inc operates a specialty retailer of home fragrance, body care, and soaps and sanitizer products. It sells its products under the Bath & Body Works, White Barn, and other brand names through retail stores and e-commerce sites located in the United States and Canada, as well as through international stores operated by partners under franchise, license, and wholesale arrangements.